erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Rhinitis D012220 10 associated lipids
Skin Ulcer D012883 6 associated lipids
Heart Diseases D006331 8 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Multiple Myeloma D009101 13 associated lipids
Quadriplegia D011782 4 associated lipids
Pain, Postoperative D010149 13 associated lipids
Porphyrias D011164 2 associated lipids
Femoral Fractures D005264 7 associated lipids
Hematuria D006417 13 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Weight Gain D015430 101 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Endocarditis, Bacterial D004697 5 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Salpingitis D012488 2 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Fractures, Open D005597 3 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Crohn Disease D003424 12 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Cholestasis D002779 23 associated lipids
Sinusitis D012852 9 associated lipids
Glomerulonephritis D005921 35 associated lipids
Sepsis D018805 11 associated lipids
Nervous System Diseases D009422 37 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Ataxia D001259 20 associated lipids
Psoriasis D011565 47 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Cross Infection D003428 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Wound Infection D014946 12 associated lipids
Bacteriuria D001437 7 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Smith RP et al. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes. 1997 J. Antimicrob. Chemother. pmid:9421315
Caron F et al. Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium. 1997 Antimicrob. Agents Chemother. pmid:9420051
Occhialini A et al. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. 1997 Antimicrob. Agents Chemother. pmid:9420046
Clancy J et al. Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae. 1997 Antimicrob. Agents Chemother. pmid:9420045
Taylor DE et al. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. 1997 Antimicrob. Agents Chemother. pmid:9420030
Sakran W et al. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides]. 1997 Harefuah pmid:9418339
Luft FC Antimicrobials in kidney and liver failure. 1976 Am Fam Physician pmid:941822
Kitazawa T et al. Functional characterization of neural and smooth muscle motilin receptors in the chicken proventriculus and ileum. 1997 Regul. Pept. pmid:9416990
Nakashio S et al. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens]. 1997 Jpn J Antibiot pmid:9412874
Nastasyak IN [Localization of rifampicin resistance determinants on genetic map of Saccharopolyspora erythraea]. 1997 Antibiot. Khimioter. pmid:9412406
Strachynskił LS et al. [Pharmacoepidemiology of antibiotics in the treatment of respiratory tract infections in pediatric outpatients]. 1997 Antibiot. Khimioter. pmid:9412396
Tsarev VN et al. [A trial of the use of rulid, sumamed and makropen in the combined treatment of generalized periodontitis at a stage of exacerbation]. 1997 Stomatologiia (Mosk) pmid:9411932
Sharrock WJ et al. Protein synthesis in Bacillus subtilis. II. Selective translation of natural mRNAs and its possible relation to the species-specific inhibition of protein synthesis by lincomycin and erythromycin. 1979 J. Mol. Biol. pmid:94104
Kiska DL and Cynamon MH Photo quiz. Tinea barbae caused by Trichophyton verrucosum. 1997 Clin. Infect. Dis. pmid:9410095
Sacristán JA et al. [Double-blind clinical trial comparing 5 days of dirithromycin versus 7 days of diacetylmidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis]. 1997 Aug-Sep Enferm. Infecc. Microbiol. Clin. pmid:9410047
Khan AM et al. Neonatal diarrhea caused by Vibrio cholerae 0139 Bengal. 1995 Diagn. Microbiol. Infect. Dis. pmid:9407221
Barry AL et al. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. 1997 Eur. J. Clin. Microbiol. Infect. Dis. pmid:9405952
Koyama H and Geddes DM Erythromycin and diffuse panbronchiolitis. 1997 Thorax pmid:9404381
Geerdes-Fenge HF et al. Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva. 1997 Eur. J. Clin. Pharmacol. pmid:9403284
Graham MY and Weisblum B Altered methylation of adenine in 23 S ribosomal RNA associated with erythromycin resistance in Streptomyces erythreus and Streptococcus fecalis. 1979 Contrib. Microbiol. Immunol. pmid:94004
Pal D et al. Reactivation of denatured proteins by domain V of bacterial 23S rRNA. 1997 Nucleic Acids Res. pmid:9396814
Maeda K et al. [Effect of cessation of erythromycin therapy on diffuse panbronchiolitis]. 1997 Nihon Kyobu Shikkan Gakkai Zasshi pmid:9396251
Woodhouse C Ulceration of a ring into a phalanx. 1976 Hand pmid:939446
Gaisser S et al. Analysis of seven genes from the eryAI-eryK region of the erythromycin biosynthetic gene cluster in Saccharopolyspora erythraea. 1997 Mol. Gen. Genet. pmid:9393448
Pelizza G et al. Polymorphism of erythromycin studied by differential thermal analysis. 1976 Farmaco Sci pmid:939324
Jamis-Dow CA et al. Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole. 1997 Am. J. Clin. Oncol. pmid:9391548
He Z and Li Y [Diffuse panbronchiolitis]. 1996 Zhonghua Jie He He Hu Xi Za Zhi pmid:9388854
Feng B et al. [Acetaminophen absorption test for determination of diabetic gastroparesis and effects of erythromycin on gastric emptying]. 1996 Zhonghua Nei Ke Za Zhi pmid:9387657
Zhao XJ and Ishizaki T Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes. 1997 Br J Clin Pharmacol pmid:9384469
Stephenson GA et al. Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity. 1997 J Pharm Sci pmid:9383733
Salcedo Abizanda S et al. [Administration of intrapartum erythromycin for the interruption of the vertical transmission of Ureaplasma urealyticum and its possible relation to the development of bronchopulmonary dysplasia in neonates with less than 32 weeks gestation. Multicenter study]. 1997 An. Esp. Pediatr. pmid:9382274
Tanaka E and Yasuhara H [Evaluation of liver function in liver diseases using drugs as indicators]. 1997 J Toxicol Sci pmid:9379499
Syphilis: recommended treatment schedules, 1976. Recommendations established by the Venereal Disease Control Advisory Committee. 1976 Ann. Intern. Med. pmid:937929
Abdelghaffar H et al. Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway: L-cladinose is involved both in alterations of neutrophil functions and modulation of this transductional pathway. 1997 J. Immunol. pmid:9378989
Sollecito TP et al. Elephantiasis nostras of the lips: a case report. 1997 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:9377195
López-Yeste ML and Lite Lite J [Loss of erythromycin sensitivity in strains of Staphylococcus aureus]. 1997 Enferm. Infecc. Microbiol. Clin. pmid:9376396
Baraia-Etxaburu J et al. [Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment]. 1997 Enferm. Infecc. Microbiol. Clin. pmid:9376391
Nawaz MS et al. Detection of erythromycin resistant methylase gene by the polymerase chain reaction. 1997 Mol. Cell. Probes pmid:9375290
Chuck JA et al. Molecular recognition of diketide substrates by a beta-ketoacyl-acyl carrier protein synthase domain within a bimodular polyketide synthase. 1997 Chem. Biol. pmid:9375254
Rohner CD and Force RW Lowering the rate of antibiotic resistance. 1997 J Fam Pract pmid:9374954
Weissman KJ et al. The molecular basis of Celmer's rules: the stereochemistry of the condensation step in chain extension on the erythromycin polyketide synthase. 1997 Biochemistry pmid:9374862
Chan LY and Chan JC Mycoplasma pneumoniae infection presenting as haemolytic anaemia. 1997 Aug 20-Sep 2 Br J Hosp Med pmid:9373409
Hueston WJ and Lenhart JG A decision analysis to guide antibiotic selection for Chlamydia infection during pregnancy. 1997 Nov-Dec Arch Fam Med pmid:9371049
Malessa R et al. Oligosymptomatic neurosyphilis with false negative CSF-VDRL in HIV-infected individuals? 1996 Eur. J. Med. Res. pmid:9367943
Morey TE et al. Ionic basis of the differential effects of intravenous anesthetics on erythromycin-induced prolongation of ventricular repolarization in the guinea pig heart. 1997 Anesthesiology pmid:9366470
Epler GR Bronchiolar disorders with airflow obstruction. 1996 Curr Opin Pulm Med pmid:9363129
Dasgupta MK et al. The effects of macrolide and quinolone antibiotics in methicillin-resistant Staphylococcus aureus biofilm growth. 1997 Adv Perit Dial pmid:9360684
Ekdahl K et al. Eradication of penicillin-resistant pneumococci in the nasopharynx with antibiotic combinations including rifampicin: experiences from the South Swedish Pneumococcal Intervention Project. 1997 Scand. J. Infect. Dis. pmid:9360252
Erythromycin resistance in Finland declines after reduction in macrolide use. 1997 Am J Health Syst Pharm pmid:9359947
Vogt AW and Zollo RA Long Q-T syndrome associated with oral erythromycin used in preoperative bowel preparation. 1997 Anesth. Analg. pmid:9356092
Lanouette JM et al. Is inflammation on Papanicolaou smear a risk factor for preterm delivery? 1997 Jul-Aug Fetal. Diagn. Ther. pmid:9354886
Summers RG et al. Sequencing and mutagenesis of genes from the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea that are involved in L-mycarose and D-desosamine production. 1997 Microbiology (Reading, Engl.) pmid:9353926
Sánchez L et al. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. 1997 J. Bacteriol. pmid:9352940
Villagrasa V et al. Effects of erythromycin on chemoattractant-activated human polymorphonuclear leukocytes. 1997 Gen. Pharmacol. pmid:9352310
Roberts ES et al. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes. 1997 Drug Metab. Dispos. pmid:9351899
Pendland SL et al. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones. 1997 J. Clin. Microbiol. pmid:9350781
Korgenski EK and Daly JA Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States. 1997 J. Clin. Microbiol. pmid:9350776
Lopardo HA et al. Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes. The Argentinian Streptococcus Study Group. 1997 Diagn. Microbiol. Infect. Dis. pmid:9350412
Klimek JJ et al. Mycoplasma pneumoniae meningoencephalitis and transverse myelitis in association with low cerebrospinal fluid glucose. 1976 Pediatrics pmid:934771
Triolo R [Nephrotoxicity of antibiotics]. 1976 Minerva Med. pmid:934504
Lookingbill DP et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. 1997 J. Am. Acad. Dermatol. pmid:9344199
Nalepa P et al. [Chlamydia pneumoniae as an etiologic agent in severe pneumonias]. 1997 Pneumonol Alergol Pol pmid:9340067
Mitsuyama T et al. Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide. 1997 Int. Arch. Allergy Immunol. pmid:9338603
Borzani M et al. A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy. 1997 J. Antimicrob. Chemother. pmid:9338507
Taylor D Pharmacokinetic interactions involving clozapine. 1997 Br J Psychiatry pmid:9337943
Ruan X et al. Acyltransferase domain substitutions in erythromycin polyketide synthase yield novel erythromycin derivatives. 1997 J. Bacteriol. pmid:9335291
Kivistö KT et al. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole. 1997 Clin. Pharmacol. Ther. pmid:9333111
Tait-Kamradt A et al. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. 1997 Antimicrob. Agents Chemother. pmid:9333056
Syrogiannopoulos GA et al. Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece. 1997 Clin. Infect. Dis. pmid:9332508
Vicarini H et al. Analysis of regulatory region of ermAM genes in streptococci and enterococci highly resistant to macrolides and lincosamides. 1997 Adv. Exp. Med. Biol. pmid:9331702
Savoia D et al. Group A streptococci. Erythromycin resistance and penicillin tolerance. 1997 Adv. Exp. Med. Biol. pmid:9331690
Jasir A and Schalén C Erythromycin resistance phenotypes in Swedish clinical isolates of group A streptococci. 1997 Adv. Exp. Med. Biol. pmid:9331689
Yang YH et al. Opacity factor inhibition test for typing group A beta-haemolytic streptococcus strains and antibiotic susceptibility. 1997 Adv. Exp. Med. Biol. pmid:9331595
Kundu S et al. Clarithromycin-induced ventricular tachycardia. 1997 Ann Emerg Med pmid:9326871
Májský A and Chudomel V Inactivation of HL-A antigens in vitro by action of antibiotics. 1976 J. Immunogenet. pmid:932464
Ballard RC et al. Delayed hypersensitivity to Chlamydia trachomatis: cause of chronic prostatitis. 1979 Lancet pmid:93221
Easterbrook SM and Hersey JA Bioautography of erythromycin and its esters. 1976 J. Chromatogr. pmid:932154
George RH and Bint AJ Letter: Treatment of a brain abscess due to Bacteroides fragilis with metronidazole. 1976 J. Antimicrob. Chemother. pmid:931828
Martin JR et al. 3'-de-o-methyl-2', 3'-anhydro-lankamycin, a new macrolide antibiotic from Streptomyces violaceoniger. 1976 Helv. Chim. Acta pmid:931757
Kopp VJ et al. Intravenous erythromycin promotes gastric emptying prior to emergency anesthesia. 1997 Anesthesiology pmid:9316982
Nichols RL et al. Preoperative bowel preparation. Erythromycin base serum and fecal levels following oral administration. 1977 Arch Surg pmid:931637
Ju J and Goo YM 8-Deoxylankolide from a lankamycin producing Streptomyces spp. 1997 J. Antibiot. pmid:9315083
Newell AM et al. Nephrotic syndrome associated with bacillary angiomatosis in a patient with AIDS. 1997 Clin. Infect. Dis. pmid:9314482
Blackman HJ et al. Antibiotic susceptibility of Chlamydia trachomatis. 1977 Antimicrob. Agents Chemother. pmid:931365
Katapadi K et al. A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report. 1997 Angiology pmid:9313632
Wilmer A et al. Gastric emptying in the critically ill--the way forward. 1997 Intensive Care Med pmid:9310823
Hegde R Gastric emptying and prokinetics. 1997 Intensive Care Med pmid:9310822
Berman S et al. Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population. 1997 Pediatrics pmid:9310510
Mercer BM et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. 1997 JAMA pmid:9307346
Roblin PM et al. In vitro activity of trovafloxacin against Chlamydia pneumoniae. 1997 Antimicrob. Agents Chemother. pmid:9303410
Ednie LM et al. Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). 1997 Antimicrob. Agents Chemother. pmid:9303406
Visalli MA et al. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. 1997 Antimicrob. Agents Chemother. pmid:9303375
Cohen MA and Huband MD In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs. 1997 J. Antimicrob. Chemother. pmid:9302005
Czambor-Ksiazek E et al. [Disorders of gastric emptying in diabetes. II. Treatment]. 1997 Wiad. Lek. pmid:9297356
Visalli MA et al. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill. 1997 Diagn. Microbiol. Infect. Dis. pmid:9294703
Martin MV et al. Acute dentoalveolar infections: an investigation of the duration of antibiotic therapy. 1997 Br Dent J pmid:9293130
Rovira A et al. Acute colonic pseudo-obstruction (Ogilvie's syndrome) treated with erythromycin. 1997 Intensive Care Med pmid:9291000
Bradley AJ and Green MJ Clinical mastitis in dairy cows after 'blitz' therapy. 1997 Vet. Rec. pmid:9290201
Aldighieri S et al. [The status of antibiotic sensitivity of Vibrio cholerae 0:1 in Ecuador]. 1997 Med Trop (Mars) pmid:9289622
Alkhawajah AM Studies on the antimicrobial activity of juglans regia. 1997 Am. J. Chin. Med. pmid:9288364